Monitor phenotypic changes related to drug resistance (such as EMT) and adjust the plan promptly.
-
Clusters detected means high risk of transmission, promptly strengthen intervention and follow-up.
-
More suitable for high-frequency monitoring than an organizational biopsy, reducing costs and patient burden.
-
Using the number of
CTCs, the proportion of clusters, and the frequency of specific mutations as indicators of efficacy and prognosis.
Test Duration: 2-3 Days
.png)
Informed Consent Form
.png)
.png)
Collect 5-10 ml of Blood
or Pleural Effusion, Ascites, Cerebrospinal Fluid-
.png)
Enrichment and Purification
-
.png)
Pathological Analysis Report
Meets any of the following (applicable to any solid tumor):
-People concerned about recurrence or metastasis after cancer surgery
-People with solid tumors who are using medication